Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 79,273 shares at $76.05 ($6.0M) on 2019-03-13, disclosed to the SEC on 2019-03-14.
Open-market sale of $6.0M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.92 | 967 | $73K | 1.2% |
| 2 | $75.92 | 1,080 | $82K | 1.4% |
| 3 | $75.92 | 1,668 | $127K | 2.1% |
| 4 | $75.92 | 9,679 | $735K | 12.2% |
| 5 | $75.92 | 63,047 | $4.8M | 79.5% |
| 6 | $76.05 | 2,832 |
| $215K |
| 3.6% |
| Total | $75.92 avg | 79,273 | $6.0M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |